Frequency
Latest
OMRI
Headlines
Johnson & Johnson says Omrix shareholders tendered about 97.8% of shares.
2:59PM 12/27/08
To Marek Fuchs, it's plain to see that some business journalists are overdoing it on a good but small acquisition by Johnson & Johnson.
11:23AM 11/25/08
Stocks on Wall Street rally on news of a federal plan to rescue ailing financial giant Citigroup and the appointment by President-elect Obama of several key economic advisers. Frank Curzio reviews the action in The Real Story video (above).
4:28PM 11/24/08
Premarket futures were hinting at a higher open for U.S. stocks Monday, following a U.S. government plan to rescue ailing financial giant Citigroup.
9:15AM 11/24/08
Johnson & Johnson plans to begin a tender offer to Omrix shares for $25 each. Omrix closed Friday at $21.16.
6:55AM 11/24/08
Seattle Genetics rises, but Alnylam falls.
4:01PM 10/27/08
King Pharmaceuticals bucks an otherwise dismal day in health stocks.
5:27PM 10/09/08
Genentech shares drop on investor concerns about financing for the company's deal with Roche but ease off their lows by the closing bell.
5:19PM 10/08/08
Shares of the company drop after announcing late-stage trial results that disappoint the Street.
5:59PM 08/12/08
Aqua America, Raymond James Financial, Steelcase, Morningstar and Liberty Media Capital all downgraded.
7:19AM 04/02/08
Understanding the Market
Our Experts' Take at RealMoney for Omrix Biopharmaceuticals Incorporated
Traders are cycling back into 'slow motion' stocks and realizing that they oversold Wal-Mart.
12:39PM 01/09/09
Once again, sentiment is in the driver's seat.
8:58AM 01/09/09
More Experts' Takes on OMRI
More popular tickers are indicated by scale.